An analysis of NESTROFT and Red cell indices in evaluating antenatal mothers for Beta Thalassemia trait

Authors

  • Rana Safia Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi 110062
  • Zeeba S Jairajpuri Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi 110062
  • Shaan Khetrapal Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi 110062
  • MJ Hassan Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi 110062
  • Monika Gupta Department of Obstetrics & Gynaecology, Vardhaman Mahavir Medical College Safdarjung Hospital, New Delhi 110029
  • Sujata Jetley Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi 110062

DOI:

https://doi.org/10.3329/bjms.v17i3.36996

Keywords:

NESTROFT, Antenatal, Thalassemia

Abstract

Background: The frequency of thalassemia trait is about 3% worldwide, while in developing countries like India, it is a major cause of burden on the health care system. Naked eye single tube red cell osmotic fragility test (NESTROFT) used in population screening for beta thalassemia trait. It is a simple, low cost, reliable and most suitable screening test for β BTT, with a sensitivity of 99.8% in regions with high prevalence rates.

Material &Methods: The present study was conducted in the Department of Pathology and included a total of 174 antenatal cases, attending the Out Patient Department of Obstetrics and Gynecology of a tertiary health care center in New Delhi between June 2011 to January 2012. The aim of the study was to screen mothers antenatally for early detection of BTT and to test the validity of NESTROFT in detection of thalassemic carriers of this area.

Results: 174 pregnant women attending antenatal clinics were screened for detecting hemoglobinopathy with the help of NESTROFT, red cell indices, haemoglobin electrophoresis and HPLC It was seen that only four cases were BTT while ten were of microcytic anaemia and two had normal red cell indices.

Conclusion: antenatal diagnosis of BTT is an important screening programme to reduce the burden of birth of children suffering from thalassemia and other hemoglobinopathies.

Bangladesh Journal of Medical Science Vol.17(3) 2018 p.411-416

Downloads

Download data is not yet available.
Abstract
1375
PDF
1014

Author Biography

Rana Safia, Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi 110062



Downloads

Published

2018-06-29

How to Cite

Safia, R., Jairajpuri, Z. S., Khetrapal, S., Hassan, M., Gupta, M., & Jetley, S. (2018). An analysis of NESTROFT and Red cell indices in evaluating antenatal mothers for Beta Thalassemia trait. Bangladesh Journal of Medical Science, 17(3), 411–416. https://doi.org/10.3329/bjms.v17i3.36996

Issue

Vol. 17 No. 3 (2018)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.